12:00 AM
 | 
Mar 19, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Veregen sinecatechins regulatory update

MediGene said 17 European countries issued positive opinions for approval of MAAs for Veregen to treat genital warts, Germany acted as the reference member state under the mutual recognition procedure. The company said "within the next...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >